日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

新辅助化疗后若疗效显著,可省略区域淋巴结照射

Mamounas, Eleftherios P; Bandos, Hanna; White, Julia R; Julian, Thomas B; Khan, Atif J; Shaitelman, Simona F; Torres, Mylin A; Vicini, Frank A; Ganz, Patricia A; McCloskey, Susan A; Lucas, Peter C; Gupta, Nilendu; Li, X Allen; McCormick, Beryl; Smith, Benjamin; Tendulkar, Rahul D; Kavadi, Vivek S; Matsumoto, Koji; Seaward, Samantha Andrews; Irvin, William J Jr; Lin, Jolinta Y; Mutter, Robert W; Muanza, Thierry M; Stromberg, Jannifer; Jagsi, Reshma; Weiss, Anna C; Curran, Walter J Jr; Wolmark, Norman

Reply to: "Annual Versus Biennial Mammographic Screening" and "Breast Cancer Screening Interval: Effects of Proportions and Biases on Benefits"

回复:“年度与两年一次的乳腺X光检查”和“乳腺癌筛查间隔:比例和偏差对获益的影响”

Zuley, Margarita L; Bandos, Andriy I; Duffy, Stephen W; Logue, Durwin; Bhargava, Rohit; McAuliffe, Priscilla F; Brufsky, Adam M; Nishikawa, Robert M

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

在NRG-BR004临床试验中使用PRO-CTCAE进行症状频繁监测的可行性

Bandos, Hanna; Kim, Sungjin; Henry, N Lynn; Hays, Ron D; Calsavara, Vinicius F; Luu, Michael; Gresham, Gillian; Lu, Kit Y; Irvin, William J Jr; Suga, J Marie; Siddique, Shahzad; Cecchini, Reena S; Rogatko, André; Yothers, Greg; Tighiouart, Mourad; Ganz, Patricia A

NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer

NRG-BR008/HERO 研究:一项针对低危 HER2 阳性乳腺癌的放射治疗优化 III 期随机试验

Braunstein, Lior Z; Mitchell, Melissa P; Bandos, Hanna; Sikov, William M; Khan, Atif J; Chen, Peter Y; Ganz, Patricia A; Jagsi, Reshma; White, Julia R; Cecchini, Reena S; Kang, Hyejoo; Puhalla, Shannon L; Bolton, Kelly L; Connolly, Eileen P; Stringer-Reasor, Erica M; Gergelis, Kimberly R; Julian, Thomas B; Mamounas, Eleftherios P; Wolmark, Norman

Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

利用毒性指数分析癌症临床试验中的不良事件和患者报告结局

Gresham, Gillian; Henry, N Lynn; Bandos, Hanna; Calsavara, Vinicius F; Cecchini, Reena S; Diniz, Marcio A; Hays, Ron D; Luu, Michael; Kim, Sungjin; Rogatko, André; Yothers, Greg; Ganz, Patricia A; Tighiouart, Mourad

Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials

癌症临床试验中患者报告结局和生活质量指标的最佳实践和实用方法

Bandos, Hanna; Torres-Saavedra, Pedro A; Culakova, Eva; Gunn, Heather J; Lee, Minji K; Duan, Fenghai; Cecchini, Reena S; Unger, Joseph M; Dueck, Amylou C; Steingrimsson, Jon A

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer

OlympiA 研究的患者报告结局:一项针对 gBRCA1/2 突变和高危人表皮生长因子受体 2 阴性早期乳腺癌患者的奥拉帕尼辅助治疗 III 期随机、安慰剂对照试验

Ganz, Patricia A; Bandos, Hanna; Španić, Tanja; Friedman, Sue; Müller, Volkmar; Kuemmel, Sherko; Delaloge, Suzette; Brain, Etienne; Toi, Masakazu; Yamauchi, Hideko; de Dueñas, Eduardo-M; Armstrong, Anne; Im, Seock-Ah; Song, Chuan-Gui; Zheng, Hong; Sarosiek, Tomasz; Sharma, Priyanka; Geng, Cuizhi; Fu, Peifen; Rhiem, Kerstin; Frauchiger-Heuer, Heike; Wimberger, Pauline; t'Kint de Roodenbeke, Daphné; Liao, Ning; Goodwin, Annabel; Chakiba-Brugère, Camille; Friedlander, Michael; Lee, Keun Seok; Giacchetti, Sylvie; Takano, Toshimi; Henao-Carrasco, Fernando; Virani, Shamsuddin; Valdes-Albini, Frances; Domchek, Susan M; Bane, Charles; McCarron, Edward C; Mita, Monica; Rossi, Giovanna; Rastogi, Priya; Fielding, Anitra; Gelber, Richard D; Scheepers, Elsemieke D; Cameron, David; Garber, Judy; Geyer, Charles E; Tutt, Andrew N J

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial

70基因MammaPrint检测在NRG Oncology/NSABP B-42试验中预测延长来曲唑治疗获益的效用

Rastogi, Priya; Bandos, Hanna; Lucas, Peter C; van 't Veer, Laura J; Wei, Jia-Perng J; Geyer, Charles E Jr; Fehrenbacher, Louis; Chia, Stephen K L; Brufsky, Adam M; Walshe, Janice M; Soori, Gamini S; Dakhil, Shaker R; Paik, Soonmyung; Swain, Sandra M; Menicucci, Andrea R; Audeh, M William; Wolmark, Norman; Mamounas, Eleftherios P

Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival

乳腺癌筛查间隔:对诊断时晚期疾病发生率和总体生存率的影响

Zuley, Margarita L; Bandos, Andriy I; Duffy, Stephen W; Logue, Durwin; Bhargava, Rohit; McAuliffe, Priscilla F; Brufsky, Adam M; Nishikawa, Robert M

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer

一项针对高危、激素受体阳性、早期乳腺癌患者的内分泌治疗±1年依维莫司治疗的III期随机、安慰剂对照试验

Chavez-MacGregor, Mariana; Miao, Jieling; Pusztai, Lajos; Goetz, Matthew P; Rastogi, Priya; Ganz, Patricia A; Mamounas, Eleftherios P; Paik, Soonmyung; Bandos, Hanna; Razaq, Wajeeha; O'Dea, Anne; Kaklamani, Virginia; Silber, Andrea L M; Flaum, Lisa E; Andreopoulou, Eleni; Wendt, Albert G; Carney, Jennifer F; Sharma, Priyanka; Gralow, Julie R; Lew, Danika L; Barlow, William E; Hortobagyi, Gabriel N